Patent ID: 8637241

Claim:
A method for distinguishing between a glioblastoma and an anaplastic astrocytoma, comprising determining the level of expression of the miRNAs in Table 6 in a test sample from a tissue suspected of being a glioblastoma or an anaplastic astrocytoma, and determining if the level is that expected of a glioblastoma or the level expected from an anaplastic astrocytoma, wherein the miRNAs in Table 6 are hsa-miR-126, hsa-miR-21, hsa-miR-146b-5p, hsa-miR-155, hsa-miR-16, hsa-miR-193a-3p, hsa-miR-199a-3p/hsa-miR-199b-3p, hsa-miR-22, hsa-miR-335, hsa-miR-143, hsa-miR-381, hsa-miR-24, hsa-miR-552, hsa-miR-886-5p, hsa-miR-142-5p, hsa-miR-34a, hsa-miR-128, hsa-miR-923, hsa-miR-513a-5p, hsa-miR-509-3-5p, hsa-miR-376c, hsa-miR-886-3p, hsa-miR-219-2-3p, hsa-miR-451.